Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Willand

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Organic & Biomolecular Chemistry|May 11, 2019
A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluationAlexandra Pastor, Arnaud Machelart, Xue Li, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 7, 2013
Structural and docking studies of potent ethionamide boostersNatalie J Tatum, Baptiste Villemagne, Nicolas Willand, et al.
European Journal of Medicinal Chemistry|September 30, 2018
Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosisMarion Prieri, Rosangela Frita, Nicolas Probst, et al.
International Journal of Molecular Sciences|December 23, 2023
Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against <i>Mycobacterium tuberculosis</i>Bruna Gioia, Francesca Ruggieri, Alexandre Biela, et al.
International Journal of Pharmaceutics|May 20, 2017
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugsGiuseppina Salzano, Jitendra Wankar, Stefano Ottani, et al.
ACS Chemical Biology|August 14, 2010
Exploring drug target flexibility using in situ click chemistry: application to a mycobacterial transcriptional regulatorNicolas Willand, Matthieu Desroses, Patrick Toto, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal ChemistryBenoit Deprez, Damien Bosc, Julie Charton, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers' LactamizationSalia Tangara, Léo Faïon, Catherine Piveteau, et al.
Organic & Biomolecular Chemistry|November 29, 2017
New active leads for tuberculosis booster drugs by structure-based drug discoveryNatalie J Tatum, John W Liebeschuetz, Jason C Cole, et al.
Biochemical and Biophysical Research Communications|April 19, 2017
Structural analysis of the interaction between spiroisoxazoline SMARt-420 and the Mycobacterium tuberculosis repressor EthR2Alexandre Wohlkönig, Han Remaut, Martin Moune, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Organic & Biomolecular Chemistry|May 11, 2019
A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluationAlexandra Pastor, Arnaud Machelart, Xue Li, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 7, 2013
Structural and docking studies of potent ethionamide boostersNatalie J Tatum, Baptiste Villemagne, Nicolas Willand, et al.
European Journal of Medicinal Chemistry|September 30, 2018
Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosisMarion Prieri, Rosangela Frita, Nicolas Probst, et al.
International Journal of Molecular Sciences|December 23, 2023
Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against <i>Mycobacterium tuberculosis</i>Bruna Gioia, Francesca Ruggieri, Alexandre Biela, et al.
International Journal of Pharmaceutics|May 20, 2017
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugsGiuseppina Salzano, Jitendra Wankar, Stefano Ottani, et al.
ACS Chemical Biology|August 14, 2010
Exploring drug target flexibility using in situ click chemistry: application to a mycobacterial transcriptional regulatorNicolas Willand, Matthieu Desroses, Patrick Toto, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal ChemistryBenoit Deprez, Damien Bosc, Julie Charton, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers' LactamizationSalia Tangara, Léo Faïon, Catherine Piveteau, et al.
Organic & Biomolecular Chemistry|November 29, 2017
New active leads for tuberculosis booster drugs by structure-based drug discoveryNatalie J Tatum, John W Liebeschuetz, Jason C Cole, et al.
Biochemical and Biophysical Research Communications|April 19, 2017
Structural analysis of the interaction between spiroisoxazoline SMARt-420 and the Mycobacterium tuberculosis repressor EthR2Alexandre Wohlkönig, Han Remaut, Martin Moune, et al.
Pageof 5